Together, these results suggest that, as an alternative to direct inhibitors of AXL, elucidation of the mechanisms underlying how AXL is regulated at the mRNA level may help develop novel AXL-targeting approaches for cancer treatment in the future. The gene discussed is AXL; the disease is cancer.